TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs80184685
log Bayes Factor = 12.8291
Chromosome 11   position 3,142,769  (GRCh37) Explore rs80184685 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
I30-I52 Other forms of heart disease
1.000 0.000 0.000
Chapter IX Diseases of the circulatory system
1.000 0.000 0.000
I50 Heart failure
1.000 0.000 0.000
# Top node
1.000 0.000 0.000
Chapter II Neoplasms
1.000 0.000 0.000
I47 Paroxysmal tachycardia
0.999 0.001 0.000
I50.1 Left ventricular failure
0.997 0.003 0.000
I47.2 Ventricular tachycardia
0.991 0.009 0.000
I05-I09 Chronic rheumatic heart diseases
0.990 0.010 0.000
Chapter XX External causes of morbidity and mortality
0.990 0.010 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.988 0.012 0.000
I50.0 Congestive heart failure
0.983 0.017 0.000
I34 Nonrheumatic mitral valve disorders
0.982 0.018 0.000
I47.1 Supraventricular tachycardia
0.979 0.021 0.000
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
0.975 0.025 0.000
C15-C26 Malignant neoplasms of digestive organs
0.973 0.027 0.000
C64-C68 Malignant neoplasms of urinary tract
0.973 0.027 0.000
I50.9 Heart failure, unspecified
0.972 0.028 0.000
I08 Multiple valve diseases
0.970 0.030 0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes
0.968 0.032 0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities
0.965 0.035 0.000
I51 Complications and ill-defined descriptions of heart disease
0.958 0.042 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.954 0.046 0.000
Y90-Y98 Supplementary factors related to causes of morbidity and mortality classified elsewhere
0.946 0.054 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.944 0.056 0.000
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions
0.940 0.060 0.000
I35 Nonrheumatic aortic valve disorders
0.934 0.066 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.932 0.068 0.000
D70 Agranulocytosis
0.929 0.071 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.926 0.074 0.000
I38 Endocarditis, valve unspecified
0.924 0.076 0.000
I34.1 Mitral (valve) prolapse
0.919 0.081 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.918 0.082 0.000
C25 Malignant neoplasm of pancreas
0.915 0.085 0.000
Chapter I Certain infectious and parasitic diseases
0.915 0.085 0.000
I08.3 Combined disorders of mitral, aortic and tricuspid valves
0.914 0.086 0.000
Y95 Nosocomial condition
0.913 0.087 0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation
0.910 0.090 0.000
C67 Malignant neoplasm of bladder
0.907 0.093 0.000
I34.0 Mitral (valve) insufficiency
0.905 0.095 0.000
C64 Malignant neoplasm of kidney, except renal pelvis
0.891 0.109 0.000
I35.0 Aortic (valve) stenosis
0.886 0.114 0.000
E00-E07 Disorders of thyroid gland
0.886 0.114 0.000
I44 Atrioventricular and left bundle-branch block
0.878 0.122 0.000
Q60-Q64 Congenital malformations of the urinary system
0.875 0.125 0.000
E20-E35 Disorders of other endocrine glands
0.875 0.125 0.000
I27 Other pulmonary heart diseases
0.871 0.129 0.000
I95-I99 Other and unspecified disorders of the circulatory system
0.870 0.130 0.000
C20 Malignant neoplasm of rectum
0.868 0.132 0.000
I60-I69 Cerebrovascular diseases
0.868 0.132 0.000
E04 Other non-toxic goitre
0.867 0.133 0.000
C77.3 Axillary and upper limb lymph nodes
0.866 0.134 0.000
I08.1 Disorders of both mitral and tricuspid valves
0.866 0.134 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.864 0.136 0.000
I31 Other diseases of pericardium
0.864 0.136 0.000
D00-D09 In situ neoplasms
0.863 0.137 0.000
C79 Secondary malignant neoplasm of other sites
0.852 0.148 0.000
I42 Cardiomyopathy
0.849 0.151 0.000
D68 Other coagulation defects
0.848 0.152 0.000
C71 Malignant neoplasm of brain
0.844 0.156 0.000
E70-E90 Metabolic disorders
0.843 0.157 0.000
C77.2 Intra-abdominal lymph nodes
0.842 0.158 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.841 0.159 0.000
D69 Purpura and other haemorrhagic conditions
0.840 0.160 0.000
C77.1 Intrathoracic lymph nodes
0.839 0.161 0.000
E04.1 Non-toxic single thyroid nodule
0.838 0.162 0.000
I51.4 Myocarditis, unspecified
0.834 0.166 0.000
C51-C58 Malignant neoplasms of female genital organs
0.833 0.167 0.000
C25.0 Head of pancreas
0.833 0.167 0.000
I46 Cardiac arrest
0.826 0.174 0.000
Chapter XIX Injury, poisoning and certain other consequences of external causes
0.825 0.175 0.000
I44.0 Atrioventricular block, first degree
0.824 0.176 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.823 0.177 0.000
Q50-Q56 Congenital malformations of genital organs
0.823 0.177 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.820 0.180 0.000
I35.2 Aortic (valve) stenosis with insufficiency
0.816 0.184 0.000
B25-B34 Other viral diseases
0.811 0.189 0.000
I45 Other conduction disorders
0.811 0.189 0.000
I31.9 Disease of pericardium, unspecified
0.810 0.190 0.000
I51.6 Cardiovascular disease, unspecified
0.807 0.193 0.000
I51.7 Cardiomegaly
0.806 0.194 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.804 0.196 0.000
A30-A49 Other bacterial diseases
0.802 0.198 0.000
C21 Malignant neoplasm of anus and anal canal
0.802 0.198 0.000
C77.5 Intrapelvic lymph nodes
0.801 0.199 0.000
W50-W64 Exposure to animate mechanical forces
0.801 0.199 0.000
C67.5 Bladder neck
0.798 0.202 0.000
I09 Other rheumatic heart diseases
0.797 0.203 0.000
I07 Rheumatic tricuspid valve diseases
0.796 0.204 0.000
Chapter V Mental and behavioural disorders
0.795 0.205 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.790 0.210 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.790 0.210 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.788 0.212 0.000
I05 Rheumatic mitral valve diseases
0.788 0.212 0.000
I27.2 Other secondary pulmonary hypertension
0.787 0.213 0.000
C15 Malignant neoplasm of oesophagus
0.786 0.214 0.000
C25.9 Pancreas, unspecified
0.786 0.214 0.000
D07.5 Prostate
0.784 0.216 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.783 0.217 0.000
I08.0 Disorders of both mitral and aortic valves
0.780 0.220 0.000
V80-V89 Other land transport accidents
0.778 0.222 0.000
Y52 Agents primarily affecting the cardiovascular system
0.778 0.222 0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified
0.776 0.224 0.000
C77.4 Inguinal and lower limb lymph nodes
0.775 0.225 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.774 0.226 0.000
Y60-Y69 Misadventures to patients during surgical and medical care
0.772 0.228 0.000
I42.9 Cardiomyopathy, unspecified
0.771 0.229 0.000
X50-X57 Overexertion, travel and privation
0.769 0.231 0.000
D68.0 Von Willebrand's disease
0.767 0.233 0.000
Q80-Q89 Other congenital malformations
0.762 0.238 0.000
Q00-Q07 Congenital malformations of the nervous system
0.761 0.239 0.000
I63 Cerebral infarction
0.759 0.241 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.755 0.245 0.000
C67.6 Ureteric orifice
0.755 0.245 0.000
C78.2 Secondary malignant neoplasm of pleura
0.754 0.246 0.000
I27.0 Primary pulmonary hypertension
0.754 0.246 0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions
0.754 0.246 0.000
D66 Hereditary factor VIII deficiency
0.753 0.247 0.000
W00-W19 Falls
0.752 0.248 0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes
0.748 0.252 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.745 0.255 0.000
I51.3 Intracardiac thrombosis, not elsewhere classified
0.745 0.255 0.000
B20-B24 Human immunodeficiency virus [HIV] disease
0.744 0.256 0.000
D69.3 Idiopathic thrombocytopenic purpura
0.744 0.256 0.000
C77.9 Lymph node, unspecified
0.742 0.258 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.741 0.259 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.739 0.261 0.000
Q61 Cystic kidney disease
0.739 0.261 0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow
0.738 0.262 0.000
D72 Other disorders of white blood cells
0.736 0.264 0.000
Chapter XXII Codes for special purposes
0.735 0.265 0.000
S60-S69 Injuries to the wrist and hand
0.735 0.265 0.000
I61 Intracerebral haemorrhage
0.735 0.265 0.000
C71.9 Brain, unspecified
0.735 0.265 0.000
I95 Hypotension
0.734 0.266 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.734 0.266 0.000
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system
0.732 0.268 0.000
I30 Acute pericarditis
0.731 0.269 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.730 0.270 0.000
C85.1 B-cell lymphoma, unspecified
0.730 0.270 0.000
I46.0 Cardiac arrest with successful resuscitation
0.728 0.272 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.728 0.272 0.000
X60-X84 Intentional self-harm
0.726 0.274 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.725 0.275 0.000
B99-B99 Other infectious diseases
0.723 0.277 0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.722 0.278 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.722 0.278 0.000
C67.8 Overlapping lesion of bladder
0.722 0.278 0.000
A49 Bacterial infection of unspecified site
0.721 0.279 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.720 0.280 0.000
E21.3 Hyperparathyroidism, unspecified
0.719 0.281 0.000
I52 Other heart disorders in diseases classified elsewhere
0.717 0.283 0.000
I48 Atrial fibrillation and flutter
0.717 0.283 0.000
I43 Cardiomyopathy in diseases classified elsewhere
0.717 0.283 0.000
I41 Myocarditis in diseases classified elsewhere
0.717 0.283 0.000
I40 Acute myocarditis
0.717 0.283 0.000
I39 Endocarditis and heart valve disorders in diseases classified elsewhere
0.717 0.283 0.000
I37 Pulmonary valve disorders
0.717 0.283 0.000
I32 Pericarditis in diseases classified elsewhere
0.717 0.283 0.000
I00-I02 Acute rheumatic fever
0.717 0.283 0.000
Chapter XVI Certain conditions originating in the perinatal period
0.717 0.283 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.717 0.283 0.000
I47.9 Paroxysmal tachycardia, unspecified
0.716 0.284 0.000
I47.0 Reentry ventricular arrhythmia
0.716 0.284 0.000
E22 Hyperfunction of pituitary gland
0.714 0.286 0.000
W20-W49 Exposure to inanimate mechanical forces
0.714 0.286 0.000
C69 Malignant neoplasm of eye and adnexa
0.713 0.287 0.000
I44.1 Atrioventricular block, second degree
0.711 0.289 0.000
I06 Rheumatic aortic valve diseases
0.710 0.290 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.710 0.290 0.000
Y35-Y36 Legal intervention and operations of war
0.710 0.290 0.000
Y10-Y34 Event of undetermined intent
0.710 0.290 0.000
Y00-Y09 Assault
0.710 0.290 0.000
X85-X99 Assault
0.710 0.290 0.000
X30-X39 Exposure to forces of nature
0.710 0.290 0.000
X10-X19 Contact with heat and hot substances
0.710 0.290 0.000
X00-X09 Exposure to smoke, fire and flames
0.710 0.290 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.710 0.290 0.000
W75-W84 Other accidental threats to breathing
0.710 0.290 0.000
W65-W74 Accidental drowning and submersion
0.710 0.290 0.000
V98-V99 Other and unspecified transport accidents
0.710 0.290 0.000
V95-V97 Air and space transport accidents
0.710 0.290 0.000
V90-V94 Water transport accidents
0.710 0.290 0.000
V70-V79 Bus occupant injured in transport accident
0.710 0.290 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.710 0.290 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.710 0.290 0.000
V40-V49 Car occupant injured in transport accident
0.710 0.290 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.710 0.290 0.000
V01-V09 Pedestrian injured in transport accident
0.710 0.290 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.709 0.291 0.000
Q63 Other congenital malformations of kidney
0.708 0.292 0.000
I51.8 Other ill-defined heart diseases
0.708 0.292 0.000
E07 Other disorders of thyroid
0.707 0.293 0.000
I34.8 Other nonrheumatic mitral valve disorders
0.704 0.296 0.000
I34.2 Nonrheumatic mitral (valve) stenosis
0.704 0.296 0.000
A80-A89 Viral infections of the central nervous system
0.703 0.297 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.703 0.297 0.000
E86 Volume depletion
0.703 0.297 0.000
I97 Postprocedural disorders of circulatory system, not elsewhere classified
0.702 0.298 0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.701 0.299 0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck
0.700 0.300 0.000
Y57 Other and unspecified drugs and medicaments
0.699 0.301 0.000
I27.8 Other specified pulmonary heart diseases
0.698 0.302 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.698 0.302 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.698 0.302 0.000
C17 Malignant neoplasm of small intestine
0.698 0.302 0.000
C23 Malignant neoplasm of gallbladder
0.698 0.302 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.697 0.302 0.000
C66 Malignant neoplasm of ureter
0.697 0.302 0.000
C65 Malignant neoplasm of renal pelvis
0.697 0.302 0.000
Y45.0 Opioids and related analgesics
0.697 0.303 0.000
C78.4 Secondary malignant neoplasm of small intestine
0.697 0.303 0.000
D68.9 Coagulation defect, unspecified
0.697 0.303 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.696 0.304 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.696 0.304 0.000
I08.9 Multiple valve disease, unspecified
0.695 0.305 0.000
I08.8 Other multiple valve diseases
0.695 0.305 0.000
I08.2 Disorders of both aortic and tricuspid valves
0.695 0.305 0.000
E04.9 Non-toxic goitre, unspecified
0.695 0.305 0.000
X20-X29 Contact with venomous animals and plants
0.695 0.305 0.000
C71.2 Temporal lobe
0.695 0.305 0.000
Y44 Agents primarily affecting blood constituents
0.694 0.306 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.694 0.306 0.000
D55-D59 Haemolytic anaemias
0.693 0.307 0.000
I69 Sequelae of cerebrovascular disease
0.693 0.307 0.000
Q90-Q99 Chromosomal abnormalities, not elsewhere classified
0.692 0.308 0.000
Q35-Q37 Cleft lip and cleft palate
0.692 0.308 0.000
Q30-Q34 Congenital malformations of the respiratory system
0.692 0.308 0.000
I33 Acute and subacute endocarditis
0.690 0.310 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.688 0.312 0.000
I99 Other and unspecified disorders of circulatory system
0.687 0.313 0.000
Y91 Evidence of alcohol involvement determined by level of intoxication
0.687 0.313 0.000
I51.5 Myocardial degeneration
0.687 0.313 0.000
I51.2 Rupture of papillary muscle, not elsewhere classified
0.687 0.313 0.000
I51.1 Rupture of chordae tendineae, not elsewhere classified
0.687 0.313 0.000
I51.0 Cardiac septal defect, acquired
0.687 0.313 0.000
E27 Other disorders of adrenal gland
0.686 0.314 0.000
Q54 Hypospadias
0.686 0.314 0.000
C16 Malignant neoplasm of stomach
0.686 0.314 0.000
I63.9 Cerebral infarction, unspecified
0.686 0.314 0.000
E79 Disorders of purine and pyrimidine metabolism
0.684 0.316 0.000
S70-S79 Injuries to the hip and thigh
0.684 0.316 0.000
D74 Methaemoglobinaemia
0.684 0.316 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.684 0.316 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.684 0.316 0.000
I45.6 Preexcitation syndrome
0.683 0.317 0.000
E04.2 Non-toxic multinodular goitre
0.682 0.318 0.000
C67.3 Anterior wall of bladder
0.682 0.318 0.000
B34 Viral infection of unspecified site
0.682 0.318 0.000
Y43 Primarily systemic agents
0.681 0.319 0.000
D73 Diseases of spleen
0.680 0.320 0.000
E26 Hyperaldosteronism
0.680 0.320 0.000
C53 Malignant neoplasm of cervix uteri
0.680 0.320 0.000
B25 Cytomegaloviral disease
0.679 0.321 0.000
Y90 Evidence of alcohol involvement determined by blood alcohol level
0.678 0.322 0.000
Y98 Lifestyle-related condition
0.678 0.322 0.000
Y97 Environmental-pollution-related condition
0.678 0.322 0.000
Y96 Work-related condition
0.678 0.322 0.000
C55 Malignant neoplasm of uterus, part unspecified
0.677 0.323 0.000
I36 Nonrheumatic tricuspid valve disorders
0.677 0.323 0.000
C88 Malignant immunoproliferative diseases
0.676 0.324 0.000
D67 Hereditary factor IX deficiency
0.674 0.326 0.000
D65 Disseminated intravascular coagulation [defibrination syndrome]
0.674 0.326 0.000
S90-S99 Injuries to the ankle and foot
0.674 0.326 0.000
B90-B94 Sequelae of infectious and parasitic diseases
0.674 0.326 0.000
A50-A64 Infections with a predominantly sexual mode of transmission
0.674 0.326 0.000
Q38-Q45 Other congenital malformations of the digestive system
0.674 0.326 0.000
D76.3 Other histiocytosis syndromes
0.673 0.327 0.000
I64 Stroke, not specified as haemorrhage or infarction
0.673 0.327 0.000
E21.0 Primary hyperparathyroidism
0.670 0.330 0.000
Q20-Q28 Congenital malformations of the circulatory system
0.670 0.330 0.000
S64 Injury of nerves at wrist and hand level
0.670 0.330 0.000
C67.2 Lateral wall of bladder
0.670 0.330 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.669 0.331 0.000
Y59 Other and unspecified vaccines and biological substances
0.668 0.332 0.000
Y58 Bacterial vaccines
0.668 0.332 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.668 0.332 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.668 0.332 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.668 0.332 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.668 0.332 0.000
Y48 Anaesthetics and therapeutic gases
0.668 0.332 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.668 0.332 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.668 0.332 0.000
F80-F89 Disorders of psychological development
0.666 0.334 0.000
E20 Hypoparathyroidism
0.666 0.334 0.000
V20-V29 Motorcycle rider injured in transport accident
0.666 0.334 0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person
0.666 0.334 0.000
C21.0 Anus, unspecified
0.665 0.335 0.000
E40-E46 Malnutrition
0.665 0.335 0.000
D03 Melanoma in situ
0.664 0.336 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.664 0.336 0.000
C95 Leukaemia of unspecified cell type
0.664 0.336 0.000
C94 Other leukaemias of specified cell type
0.664 0.336 0.000
C93 Monocytic leukaemia
0.664 0.336 0.000
C86 Other specified types of T/NK-cell lymphoma
0.664 0.336 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.664 0.336 0.000
C81 Hodgkin's disease
0.663 0.337 0.000
I95.9 Hypotension, unspecified
0.663 0.337 0.000
I51.9 Heart disease, unspecified
0.662 0.338 0.000
C91 Lymphoid leukaemia
0.660 0.339 0.000
C71.1 Frontal lobe
0.659 0.341 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.659 0.341 0.000
D09 Carcinoma in situ of other and unspecified sites
0.659 0.341 0.000
E83 Disorders of mineral metabolism
0.659 0.341 0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.658 0.341 0.000
C70 Malignant neoplasm of meninges
0.658 0.341 0.000
I09.9 Rheumatic heart disease, unspecified
0.658 0.342 0.000
I07.1 Tricuspid insufficiency
0.657 0.342 0.000
C25.8 Overlapping lesion of pancreas
0.656 0.344 0.000
C25.7 Other parts of pancreas
0.656 0.344 0.000
C25.4 Endocrine pancreas
0.656 0.344 0.000
C25.3 Pancreatic duct
0.656 0.344 0.000
C25.2 Tail of pancreas
0.656 0.344 0.000
C25.1 Body of pancreas
0.656 0.344 0.000
B85-B89 Pediculosis, acariasis and other infestations
0.656 0.344 0.000
B50-B64 Protozoal diseases
0.656 0.344 0.000
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers
0.656 0.344 0.000
A75-A79 Rickettsioses
0.656 0.344 0.000
A70-A74 Other diseases caused by chlamydiae
0.656 0.344 0.000
A65-A69 Other spirochaetal diseases
0.656 0.344 0.000
A20-A28 Certain zoonotic bacterial diseases
0.656 0.344 0.000
A15-A19 Tuberculosis
0.656 0.344 0.000
E04.0 Non-toxic diffuse goitre
0.656 0.344 0.000
D69.5 Secondary thrombocytopenia
0.655 0.345 0.000
I05.0 Mitral stenosis
0.653 0.347 0.000
I28 Other diseases of pulmonary vessels
0.652 0.348 0.000
C15.9 Oesophagus, unspecified
0.651 0.349 0.000
C67.7 Urachus
0.650 0.349 0.000
C67.1 Dome of bladder
0.650 0.349 0.000
C67.0 Trigone of bladder
0.650 0.349 0.000
T20-T25 Burns and corrosions of external body surface, specified by site
0.650 0.350 0.000
B02 Zoster [herpes zoster]
0.649 0.351 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.649 0.351 0.000
C67.9 Bladder, unspecified
0.645 0.355 0.000
B65-B83 Helminthiases
0.645 0.355 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.644 0.356 0.000
I35.9 Aortic valve disorder, unspecified
0.642 0.358 0.000
D68.6 Other Thrombophilia
0.642 0.358 0.000
I42.8 Other cardiomyopathies
0.641 0.359 0.000
D75 Other diseases of blood and blood-forming organs
0.639 0.361 0.000
T15-T19 Effects of foreign body entering through natural orifice
0.639 0.361 0.000
C77.8 Lymph nodes of multiple regions
0.637 0.363 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.637 0.363 0.000
C34 Malignant neoplasm of bronchus and lung
0.636 0.364 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.635 0.365 0.000
E00 Congenital iodine-deficiency syndrome
0.635 0.365 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.635 0.365 0.000
S61 Open wound of wrist and hand
0.634 0.366 0.000
C09 Malignant neoplasm of tonsil
0.633 0.367 0.000
C56 Malignant neoplasm of ovary
0.632 0.368 0.000
E88 Other metabolic disorders
0.631 0.369 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.631 0.369 0.000
I70-I79 Diseases of arteries, arterioles and capillaries
0.630 0.370 0.000
I44.6 Other and unspecified fascicular block
0.629 0.371 0.000
I44.5 Left posterior fascicular block
0.629 0.371 0.000
I44.4 Left anterior fascicular block
0.629 0.371 0.000
I44.3 Other and unspecified atrioventricular block
0.629 0.371 0.000
Q64 Other congenital malformations of urinary system
0.627 0.373 0.000
Q60 Renal agenesis and other reduction defects of kidney
0.627 0.373 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.627 0.373 0.000
E34 Other endocrine disorders
0.627 0.373 0.000
E32 Diseases of thymus
0.627 0.373 0.000
E31 Polyglandular dysfunction
0.627 0.373 0.000
E30 Disorders of puberty, not elsewhere classified
0.627 0.373 0.000
E25 Adrenogenital disorders
0.627 0.373 0.000
Q51 Congenital malformations of uterus and cervix
0.627 0.373 0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified
0.626 0.374 0.000
Chapter VIII Diseases of the ear and mastoid process
0.626 0.374 0.000
A49.8 Other bacterial infections of unspecified site
0.625 0.375 0.000
I27.9 Pulmonary heart disease, unspecified
0.624 0.375 0.000
I27.1 Kyphoscoliotic heart disease
0.624 0.375 0.000
T00-T07 Injuries involving multiple body regions
0.624 0.376 0.000
E24 Cushing's syndrome
0.623 0.377 0.000
Y40 Systemic antibiotics
0.623 0.377 0.000
I68 Cerebrovascular disorders in diseases classified elsewhere
0.622 0.378 0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.622 0.378 0.000
E04.8 Other specified non-toxic goitre
0.622 0.378 0.000
B24 Unspecified human immunodeficiency virus [HIV] disease
0.621 0.379 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.619 0.380 0.000
C85.0 Lymphosarcoma
0.619 0.380 0.000
I31.8 Other specified diseases of pericardium
0.619 0.380 0.000
I31.2 Haemopericardium, not elsewhere classified
0.619 0.380 0.000
I31.1 Chronic constrictive pericarditis
0.619 0.380 0.000
I31.0 Chronic adhesive pericarditis
0.619 0.380 0.000
I45.3 Trifascicular block
0.619 0.381 0.000
X59 Exposure to unspecified factor
0.619 0.381 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.619 0.381 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.619 0.381 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.619 0.381 0.000
I62 Other nontraumatic intracranial haemorrhage
0.619 0.381 0.000
D07.1 Vulva
0.618 0.381 0.000
S10-S19 Injuries to the neck
0.618 0.382 0.000
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs
0.617 0.383 0.000
C07 Malignant neoplasm of parotid gland
0.617 0.383 0.000
A49.9 Bacterial infection, unspecified
0.616 0.384 0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments
0.615 0.385 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.615 0.385 0.000
C78.1 Secondary malignant neoplasm of mediastinum
0.615 0.385 0.000
E29 Testicular dysfunction
0.615 0.385 0.000
C79.6 Secondary malignant neoplasm of ovary
0.612 0.388 0.000
X51 Travel and motion
0.611 0.389 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.611 0.389 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.611 0.389 0.000
D69.6 Thrombocytopenia, unspecified
0.611 0.389 0.000
T08-T14 Injuries to unspecified part of trunk, limb or body region
0.609 0.391 0.000
I42.7 Cardiomyopathy due to drugs and other external agents
0.609 0.391 0.000
I42.6 Alcoholic cardiomyopathy
0.609 0.391 0.000
I42.5 Other restrictive cardiomyopathy
0.609 0.391 0.000
I42.4 Endocardial fibroelastosis
0.609 0.391 0.000
I42.3 Endomyocardial (eosinophilic) disease
0.609 0.391 0.000
D68.4 Acquired coagulation factor deficiency
0.608 0.392 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.608 0.392 0.000
D68.1 Hereditary factor XI deficiency
0.608 0.392 0.000
Q61.2 Polycystic kidney, adult type
0.607 0.393 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.606 0.394 0.000
C71.8 Overlapping lesion of brain
0.605 0.395 0.000
C71.7 Brain stem
0.605 0.395 0.000
C71.6 Cerebellum
0.605 0.395 0.000
C71.5 Cerebral ventricle
0.605 0.395 0.000
C71.4 Occipital lobe
0.605 0.395 0.000
C71.3 Parietal lobe
0.605 0.395 0.000
C71.0 Cerebrum, except lobes and ventricles
0.605 0.395 0.000
A48 Other bacterial diseases, not elsewhere classified
0.605 0.395 0.000
W08 Fall involving other furniture
0.604 0.396 0.000
S20-S29 Injuries to the thorax
0.604 0.396 0.000
E85 Amyloidosis
0.604 0.396 0.000
E84 Cystic fibrosis
0.604 0.396 0.000
E77 Disorders of glycoprotein metabolism
0.604 0.396 0.000
E76 Disorders of glycosaminoglycan metabolism
0.604 0.396 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.604 0.396 0.000
E74 Other disorders of carbohydrate metabolism
0.604 0.396 0.000
E73 Lactose intolerance
0.604 0.396 0.000
E72 Other disorders of amino-acid metabolism
0.604 0.396 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.604 0.396 0.000
E70 Disorders of aromatic amino-acid metabolism
0.604 0.396 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.604 0.396 0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs
0.603 0.397 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.603 0.397 0.000
Y52.1 Calcium-channel blockers
0.603 0.397 0.000
D69.9 Haemorrhagic condition, unspecified
0.602 0.398 0.000
D69.8 Other specified haemorrhagic conditions
0.602 0.398 0.000
D69.4 Other primary thrombocytopenia
0.602 0.398 0.000
D69.2 Other nonthrombocytopenic purpura
0.602 0.398 0.000
D69.1 Qualitative platelet defects
0.602 0.398 0.000
D69.0 Allergic purpura
0.602 0.398 0.000
Q07 Other congenital malformations of nervous system
0.602 0.398 0.000
E89.0 Postprocedural hypothyroidism
0.602 0.398 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.601 0.398 0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use
0.601 0.399 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.600 0.400 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.600 0.400 0.000
D68.5 Primary Thrombophilia
0.599 0.401 0.000
W03 Other fall on same level due to collision with, or pushing by, another person
0.599 0.401 0.000
I45.5 Other specified heart block
0.599 0.401 0.000
V10-V19 Pedal cyclist injured in transport accident
0.598 0.402 0.000
T90 Sequelae of injuries of head
0.598 0.402 0.000
C67.4 Posterior wall of bladder
0.597 0.403 0.000
C57 Malignant neoplasm of other and unspecified female genital organs
0.597 0.403 0.000
C51 Malignant neoplasm of vulva
0.597 0.403 0.000
C58 Malignant neoplasm of placenta
0.597 0.403 0.000
C52 Malignant neoplasm of vagina
0.597 0.403 0.000
C21.1 Anal canal
0.597 0.403 0.000
I35.8 Other aortic valve disorders
0.595 0.405 0.000
F40-F48 Neurotic, stress-related and somatoform disorders
0.595 0.405 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.595 0.405 0.000
T92 Sequelae of injuries of upper limb
0.595 0.405 0.000
Q61.3 Polycystic kidney, unspecified
0.593 0.406 0.000
T93 Sequelae of injuries of lower limb
0.594 0.406 0.000
I46.1 Sudden cardiac death, so described
0.592 0.407 0.000
W18 Other fall on same level
0.591 0.409 0.000
T33-T35 Frostbite
0.591 0.409 0.000
T26-T28 Burns and corrosions confined to eye and internal organs
0.591 0.409 0.000
T91 Sequelae of injuries of neck and trunk
0.590 0.410 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.590 0.410 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.590 0.410 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.590 0.410 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.590 0.410 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.590 0.410 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.590 0.410 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.590 0.410 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.590 0.410 0.000
Y51.0 Anticholinesterase agents
0.590 0.410 0.000
Y65 Other misadventures during surgical and medical care
0.590 0.410 0.000
Q56 Indeterminate sex and pseudohermaphroditism
0.590 0.410 0.000
Q55 Other congenital malformations of male genital organs
0.590 0.410 0.000
Q53 Undescended testicle
0.590 0.410 0.000
Q52 Other congenital malformations of female genitalia
0.590 0.410 0.000
I42.2 Other hypertrophic cardiomyopathy
0.590 0.410 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.589 0.411 0.000
B15-B19 Viral hepatitis
0.588 0.412 0.000
D07.6 Other and unspecified male genital organs
0.588 0.412 0.000
D07.4 Penis
0.588 0.412 0.000
D07.3 Other and unspecified female genital organs
0.588 0.412 0.000
D07.2 Vagina
0.588 0.412 0.000
D07.0 Endometrium
0.588 0.412 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.587 0.412 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.586 0.414 0.000
B99 Other and unspecified infectious diseases
0.585 0.414 0.000
I61.8 Other intracerebral haemorrhage
0.585 0.415 0.000
B25.9 Cytomegaloviral disease, unspecified
0.585 0.415 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.